Am J Psychiatry. 1988 Jan;145(1):93-5.

Response of psychotic and nonpsychotic depression to phenelzine.

Janicak PG, Pandey GN, Davis JM, Boshes R, Bresnahan D, Sharma R.

Source

Illinois State Psychiatric Institute, Chicago 60612.

Abstract

The authors studied 52 depressed inpatients to examine treatment response to phenelzine, a monoamine oxidase (MAO) inhibitor. All patients were classified into one of three RDC categories (definitely psychotic, probably psychotic, and nonpsychotic). For the entire sample, the mean platelet MAO inhibition level achieved with phenelzine was greater than 80%. Response to treatment was determined by independent clinical assessment and by the change in rating scores from baseline; 68% of the nonpsychotic, 43% of the probably psychotic, and 21% of the definitely psychotic patients were classified as responders. This differential response rate is similar to that reported in the literature for tricyclic antidepressants.

PMID:: 3337297; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Supplemental Content

Icon for Silverchair Information Systems

Save items

Related citations in PubMed

MAO inhibition and clinical response in depressed patients treated with phenelzine. [J Clin Psychiatry. 1990]
MAO inhibition and clinical response in depressed patients treated with phenelzine.
Bresnahan DB, Pandey GN, Janicak PG, Sharma R, Boshes RA, Chang SS, Gierl BL, Davis JM. J Clin Psychiatry. 1990 Feb; 51(2):47-50.
Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants. [J Clin Psychiatry. 1987]
Response of psychotic and nonpsychotic depressed patients to tricyclic antidepressants.
Chan CH, Janicak PG, Davis JM, Altman E, Andriukaitis S, Hedeker D. J Clin Psychiatry. 1987 May; 48(5):197-200.
Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression. [Am J Psychiatry. 1990]
Response to treatment with antidepressants of patients with severe or moderate nonpsychotic depression and of patients with psychotic depression.
Kocsis JH, Croughan JL, Katz MM, Butler TP, Secunda S, Bowden CL, Davis JM. Am J Psychiatry. 1990 May; 147(5):621-4.
Review Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? [Am J Psychiatry. 1992]
Review Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?
Schatzberg AF, Rothschild AJ. Am J Psychiatry. 1992 Jun; 149(6):733-45.
Review [Atypical depression: evolution toward a specific pharmacologic and efficacious treatment?]. [Can J Psychiatry. 1995]
Review [Atypical depression: evolution toward a specific pharmacologic and efficacious treatment?].
Dassylva B, Fontaine R. Can J Psychiatry. 1995 Mar; 40(2):102-8.

See reviews... See all...

Cited by 2 PubMed Central articles

The selegiline transdermal system (emsam): a therapeutic option for the treatment of major depressive disorder. [P T. 2008]
The selegiline transdermal system (emsam): a therapeutic option for the treatment of major depressive disorder.
Jessen L, Kovalick LJ, Azzaro AJ. P T. 2008 Apr; 33(4):212-46.
A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression. [Prim Care Companion J Clin Psy...]
A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression.
Culpepper L, Kovalick LJ. Prim Care Companion J Clin Psychiatry. 2008; 10(1):25-30.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Response of psychotic and nonpsychotic depression to phenelzine.
Response of psychotic and nonpsychotic depression to phenelzine.
Am J Psychiatry. 1988 Jan ;145(1):93-5.

PubMed
Lymphocytic choriomeningitis virus. X. Demonstration of nucleoprotein on the sur...
Lymphocytic choriomeningitis virus. X. Demonstration of nucleoprotein on the surface of infected cells.
Virology. 1988 Jan ;162(1):90-7.

PubMed
Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled stu...
Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study.
JAMA. 1988 Jan 22-29 ;259(4):527-32.

PubMed
Conformational requirements of substrates for activity with phenylethanolamine N...
Conformational requirements of substrates for activity with phenylethanolamine N-methyltransferase.
J Med Chem. 1988 Jan ;31(1):169-71.

PubMed
Statistics and ethics in surgery and anesthesia.
Statistics and ethics in surgery and anesthesia.
Science. 1977 Nov 18 ;198(4318):684-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: